Cross acquires a majority stake in Micromacinazione as part of a succession solution. continue...
Possibility to produce nanoparticles by supercritical fluid precipitation fully under cGMP conditions. continue...
Micromacinazione takes over micronization division of Neo-Micro AG
A novel engineering platform to enhance the dissolution rate of poorly soluble drugs.
Cross acquires a majority stake in Micromacinazione as part of a succession solution.
We are glad to announce that recently (28-30 March 2012) we passed a 3-day FDA inspection successfully
at both our manufacturing sites, Molinazzo di Monteggio and Madonna del Piano, without any observation.
Possibility to produce nanoparticles by super-
critical fluid precipitation
under fully cGMP conditions.